JP2004521618A - 新規変異体アレルゲン - Google Patents

新規変異体アレルゲン Download PDF

Info

Publication number
JP2004521618A
JP2004521618A JP2002543671A JP2002543671A JP2004521618A JP 2004521618 A JP2004521618 A JP 2004521618A JP 2002543671 A JP2002543671 A JP 2002543671A JP 2002543671 A JP2002543671 A JP 2002543671A JP 2004521618 A JP2004521618 A JP 2004521618A
Authority
JP
Japan
Prior art keywords
allergen
recombinant
mutant
bet
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002543671A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004521618A5 (enExample
Inventor
イェンス ホルム
ヘンリック イプセン
ラルセン イェルゲン ネーデルガールド
ミハエル ドー スパングホルト
Original Assignee
アルカベロ アクチェセルスカプ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27222455&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2004521618(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by アルカベロ アクチェセルスカプ filed Critical アルカベロ アクチェセルスカプ
Publication of JP2004521618A publication Critical patent/JP2004521618A/ja
Publication of JP2004521618A5 publication Critical patent/JP2004521618A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43568—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from wasps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43572—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from bees
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Insects & Arthropods (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Transplantation (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2002543671A 2000-11-16 2001-11-16 新規変異体アレルゲン Pending JP2004521618A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24936100P 2000-11-16 2000-11-16
DKPA200001718 2000-11-16
US29817001P 2001-06-14 2001-06-14
PCT/DK2001/000764 WO2002040676A2 (en) 2000-11-16 2001-11-16 Mutant allergens

Publications (2)

Publication Number Publication Date
JP2004521618A true JP2004521618A (ja) 2004-07-22
JP2004521618A5 JP2004521618A5 (enExample) 2006-02-09

Family

ID=27222455

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002543671A Pending JP2004521618A (ja) 2000-11-16 2001-11-16 新規変異体アレルゲン

Country Status (17)

Country Link
EP (1) EP1373510B1 (enExample)
JP (1) JP2004521618A (enExample)
KR (1) KR100919914B1 (enExample)
CN (1) CN100577804C (enExample)
AT (1) ATE414773T1 (enExample)
AU (2) AU2350502A (enExample)
CA (1) CA2429172C (enExample)
CZ (1) CZ20031653A3 (enExample)
DE (1) DE60136653D1 (enExample)
DK (1) DK1373510T3 (enExample)
ES (1) ES2317955T3 (enExample)
HU (1) HUP0302601A3 (enExample)
MX (1) MXPA03004174A (enExample)
NO (1) NO329721B1 (enExample)
NZ (1) NZ525820A (enExample)
PL (1) PL214225B1 (enExample)
WO (1) WO2002040676A2 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011239781A (ja) * 2010-05-18 2011-12-01 Stallergenes Sa 免疫療法と診断を目的としてピキア・パストリスにおいて“天然様”アレルゲンとして発現する組み換えＤｅｒｐ２
JP2013516962A (ja) * 2010-01-14 2013-05-16 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング プロリン残基の突然変異誘発により低減したアレルゲン性を有するイネ科のグループ５アレルゲンの変異体
JP2014515752A (ja) * 2011-04-18 2014-07-03 テクノロジアン・トゥトキムスケスクス・ブイティティー 低刺激性アレルゲン
JP2018058856A (ja) * 2013-06-06 2018-04-12 アネルギ エスアー イエダニアレルギーの処置のための連続したオーバーラップペプチド

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020051794A1 (en) 2000-08-09 2002-05-02 Alk-Abello A/S Novel parenteral vaccine formulations and uses thereof
EP1504089A2 (en) * 2002-05-16 2005-02-09 Alk Abell A/S Allergen mutants
FR2841906B1 (fr) * 2002-07-05 2006-08-18 Stallergenes Sa Molecule d'acide nucleique codant une preproproteine d'allergene d'un acarien du genre dermatophagoides ou euroglyphus et son utilisation pour la production dudit allergene dans les plantes
JP2006520184A (ja) 2002-11-01 2006-09-07 アルカベロ アクチェセルスカプ 組換えタンパク質変種
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
CA2516291C (en) 2003-02-28 2012-02-14 Alk-Abello A/S Dosage form having a saccharide matrix
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
JP4782671B2 (ja) * 2003-06-04 2011-09-28 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 低減したアレルギー誘発性および保持されたＴ細胞反応性を有するＰｈｌｐ５ａ誘導体
EP2272502A1 (en) 2003-12-19 2011-01-12 Alk-Abelló A/S Cryogranules of a liquid composition of an allergen product
CN102657863A (zh) * 2003-12-19 2012-09-12 爱尔开-阿贝优公司 用于活性药剂的低温制粒和贮藏的方法
EP1756150A2 (en) * 2004-04-23 2007-02-28 Novozymes A/S Group 1 mite polypeptide variants
US20060115499A1 (en) * 2004-09-27 2006-06-01 Alk-Abello A/S Liquid allergy vaccine formulation for oromucosal administration
US20060121063A1 (en) * 2004-10-22 2006-06-08 Novozymes A/S Group 2 mite polypeptide variants
ES2424229T3 (es) 2005-03-18 2013-09-30 Cytos Biotechnology Ag Proteínas de fusión de alérgenos de gato y utilización de las mismas
EP2324850A1 (en) 2005-10-04 2011-05-25 Alk-Abelló A/S Solid vaccine formulation
DK1814516T3 (da) * 2005-11-04 2013-03-25 Alk Abello As Anvendelse af en flydende allergivaccineformulering til oromucosal indgivelse
CA2628226A1 (en) * 2005-11-04 2007-05-10 Alk-Abello A/S Use of a liquid allergy vaccine formulation for oromucosal administration
ITMI20052517A1 (it) * 2005-12-29 2007-06-30 Lofarma Spa Varianbtio ipoallergeniche dell'allergene maggiore bet v 1 di polline di betula verrucosa
AT503297B1 (de) * 2006-05-18 2007-09-15 Biomay Ag Allergen-spezifische antikörper
AT503690A1 (de) 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
EP1908777B1 (en) * 2006-10-06 2016-02-03 Stallergenes Mite fusion proteins
EP1974746B1 (en) 2007-03-28 2012-01-11 Alk-Abelló A/S Use of an adjuvanted allergy vaccine formulation for parenteral administration
BRPI0815395A2 (pt) 2007-08-15 2015-02-10 Circassia Ltd Composição, vetor, produto, formulação farmacêutica, me´todo in vitro para determinar se as células t reconhecem um polipeptídeo, e, método in vitro para determinar se um indivíduo se encontra ou está em risco de uma condição.
DE202008006598U1 (de) 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
WO2010146171A1 (en) 2009-06-19 2010-12-23 Alk-Abelló A/S Novel manner of administering allergen in allergen specific immunotherapy
FI20115375A0 (fi) 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy Uudet hypoallergeenit
ITMI20112301A1 (it) * 2011-12-19 2013-06-20 Lofarma Spa Varianti ipoallergeniche dell'allergene maggiore phl p 5 di phleum pratense
EP2692732A1 (en) 2012-08-03 2014-02-05 Stallergenes S.A. Novel allergen from ragweed pollen and uses thereof
NZ707615A (en) 2012-10-30 2019-01-25 Aravax Pty Ltd Novel immunotherapeutic molecules and uses thereof
EP3050040A2 (en) 2013-09-24 2016-08-03 Fibar Group S.A. Intelligent smoke sensor
WO2015042664A1 (en) 2013-09-25 2015-04-02 Monash University Novel immunotherapeutic composition and uses thereof
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
US9898175B2 (en) 2014-08-05 2018-02-20 Fibar Group S.A. Home network manager for home automation
EP3269730A1 (en) * 2016-07-12 2018-01-17 Universität Salzburg Allergen variant
EP3625332B1 (en) * 2017-05-19 2022-02-02 F. Hoffmann-La Roche AG Method for the production of thymocyte supernatant
CN110093336B (zh) * 2018-01-29 2023-03-24 上海雅心生物技术有限公司 一种稳定的胰蛋白酶及其制备方法
RU2761431C9 (ru) 2020-10-26 2022-04-18 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства России (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) Рекомбинантный полипептид на основе аллергена пыльцы березы и аллергена яблока в качестве вакцины от аллергии
JP2025520496A (ja) * 2022-06-17 2025-07-03 ダンマルクス テクニスケ ウニベルシテット コンセンサスアレルゲンに基づくアレルギーワクチン

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1874997A (en) * 1996-02-15 1997-09-02 Pangenetics B.V. Molecules for the induction of immunological tolerance
DE19713001A1 (de) * 1997-03-27 1998-10-01 Merck Patent Gmbh Graminaenpollenallergenmutanten zur spezifischen Immuntherapie, deren Herstellung und Verwendung
CA2319437C (en) * 1998-01-31 2009-06-16 University Of Arkansas Methods and reagents for decreasing allergic reactions
AU749749B2 (en) * 1998-03-16 2002-07-04 Alk-Abello A/S Mutant recombinant allergens

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013516962A (ja) * 2010-01-14 2013-05-16 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング プロリン残基の突然変異誘発により低減したアレルゲン性を有するイネ科のグループ５アレルゲンの変異体
JP2011239781A (ja) * 2010-05-18 2011-12-01 Stallergenes Sa 免疫療法と診断を目的としてピキア・パストリスにおいて“天然様”アレルゲンとして発現する組み換えＤｅｒｐ２
JP2014515752A (ja) * 2011-04-18 2014-07-03 テクノロジアン・トゥトキムスケスクス・ブイティティー 低刺激性アレルゲン
US9856296B2 (en) 2011-04-18 2018-01-02 Desentum Oy Hypoallergen
JP2018058856A (ja) * 2013-06-06 2018-04-12 アネルギ エスアー イエダニアレルギーの処置のための連続したオーバーラップペプチド

Also Published As

Publication number Publication date
AU2002223505B2 (en) 2006-12-07
ES2317955T3 (es) 2009-05-01
CN100577804C (zh) 2010-01-06
NO329721B1 (no) 2010-12-06
CA2429172A1 (en) 2002-05-23
EP1373510A2 (en) 2004-01-02
DK1373510T3 (da) 2009-02-23
NO20032213D0 (no) 2003-05-15
WO2002040676A2 (en) 2002-05-23
HUP0302601A3 (en) 2010-01-28
EP1373510B1 (en) 2008-11-19
KR20030076577A (ko) 2003-09-26
MXPA03004174A (es) 2004-12-02
PL214225B1 (pl) 2013-07-31
CZ20031653A3 (en) 2004-03-17
CA2429172C (en) 2012-03-20
NO20032213L (no) 2003-07-02
HUP0302601A2 (hu) 2003-11-28
HK1060371A1 (en) 2004-08-06
DE60136653D1 (de) 2009-01-02
NZ525820A (en) 2005-01-28
PL362273A1 (en) 2004-10-18
KR100919914B1 (ko) 2009-10-06
CN1484699A (zh) 2004-03-24
WO2002040676A3 (en) 2003-10-09
AU2350502A (en) 2002-05-27
ATE414773T1 (de) 2008-12-15

Similar Documents

Publication Publication Date Title
KR100919914B1 (ko) 신규한 돌연변이체 알레르겐
CN1332029C (zh) 突变的重组过敏原
AU2002223505A1 (en) Mutant allergens
JP2004521618A5 (enExample)
JP6068544B2 (ja) アレルギーの治療に用いるための、主要グループ１ダニアレルゲンおよび主要グループ２ダニアレルゲンの低アレルゲン性ハイブリッドタンパク質
CA2486112A1 (en) Allergen mutants
US20090054625A1 (en) Recombinant protein variants
US20110052639A1 (en) Allergen mutants
RU2285042C2 (ru) Новые мутантные аллергены
US20030175312A1 (en) Novel mutant allergens
JP4253122B2 (ja) アレルゲンの非アナフィラキシー形およびその使用
JP2002507425A (ja) セリンプロテアーゼであるヒトｃａｓｂ１２ポリペプチド
JP2003526320A (ja) 複数の腫瘍において過剰発現される抗原ｃａｓｂ４１４
HK1060371B (en) Mutant allergens
ZA200303667B (en) Novel mutant allergens.
Bonura et al. Genetic engineering of allergens for immunotherapy
TWI276636B (en) Modified mite allergen and pharmaceutical uses thereof
EP1558740A2 (en) Recombinant protein variants

Legal Events

Date Code Title Description
A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20041116

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20041116

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070903

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20071203

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20071210

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080227

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080811